Skip to main content
Fig. 5 | BMC Infectious Diseases

Fig. 5

From: Epidemiologic and clinical parameters of West Nile virus infections in humans: a scoping review

Fig. 5

Clinical risk factors for developing neuroinvasive disease and for mortality in West Nile virus infection. Point estimates are measures of association (95% CI). Data on diabetes (a-b), hypertension (c-d), cancer (e-f) and immunosuppression (g-h) are shown

A. AFP/WNE v. WNF [58]

B. WNE [44]

 WNE v. WNF [44]

 WNE [35]

 WNE v. WNM/WNF [35]

 WNE/WNM [37]

 WNE v. Non-WNV* [60]

 All [79]

 WNE v. WNF [40]

 All [24]

 WNM v. WNF [40]

 All [23]

 WNND v. WNF [59]

 All [50]

 WNND v. WNF [32]

 

 WNF v. Asymptomatic [81]

 

 All v. Non-WNV [49]

 

C. AFP/WNE v. WNF [58]

D. WNE [44]

 AFP/WNM v. WNF [58]

 WNE [35]

 WNE v. WNM/WNF [35]

 WNE/WNM [37]

 WNE v. WNF [44]

 All [23]

 WNE v. WNF [40]

 All [79]

 WNE v. Non-WNV* [60]

 

 WNM v. WNF [40]

 

 WNND v. WNF [59]

 

 WNND v. WNF [32]

 

 WNF v. Asymptomatic [82]

 

 WNF v. Asymptomatic [81]

 

 All v. Non-WNV [49]

 

E. AFP/WNE v. WNF [58]

F. WNE [44]

 WNE v. WNF [44]

 WNE [35]

 WNE v. WNM/WNF [35]

 All [79]

 WNE v. WNF [40]

 

 WNE v. Non-WNV* [60]

 

 WNM v. WNF [40]

 

 All v. Non-WNV [49]

 

G. WNE v. WNF [44]

H. AFP/WNE [58]

 WNE v. WNM/WNF [35]

 WNE [44]

 WNE v. Non-WNV* [60]

 WNE [35]

 

 WNE/WNM [37]

 

 All [23]

 

 All [50]

 

 All [79]

Back to article page